1887

Abstract

Recombinant measles virus (rMV) vectors expressing heterologous viral membrane protein antigens are potentially useful as vaccines. Genes encoding the mumps virus haemagglutinin-neuraminidase (MuV-HN), the influenza virus haemagglutinin (Flu-HA) or the respiratory syncytial virus fusion (RSV-F) proteins were inserted into the genome of a live attenuated vaccine strain of measles virus. Additionally, in this case rMV with the MuV-HN or the influenza HA inserts, chimeric constructs were created that harboured the measles virus native haemagglutinin or fusion protein cytoplasmic domains. In all three cases, sucrose-gradient purified preparations of rMV were found to have incorporated the heterologous viral membrane protein on the viral membrane. The possible utility of rMV expressing RSV-F (rMV.RSV-F) as a vaccine was tested in a cotton rat challenge model. Vaccination with rMV.RSV-F efficiently induced neutralizing antibodies against RSV and protected animals from infection with RSV in the lungs.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000523
2016-09-01
2020-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/9/2117.html?itemId=/content/journal/jgv/10.1099/jgv.0.000523&mimeType=html&fmt=ahah

References

  1. Albrecht P., Herrmann K., Burns G. R.. 1981; Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods3:251–260[PubMed][CrossRef]
    [Google Scholar]
  2. Bolton D. L., Santra S., Swett-Tapia C., Custers J., Song K., Balachandran H., Mach L., Naim H., Kozlowski P. A. et al. 2012; Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates. Vaccine30:5991–5998 [CrossRef][PubMed]
    [Google Scholar]
  3. Boukhvalova M. S., Prince G. A., Blanco J. C.. 2009; The cotton rat model of respiratory viral infections. Biologicals37:152–159 [CrossRef][PubMed]
    [Google Scholar]
  4. Brandenburg B., Koudstaal W., Goudsmit J., Klaren V., Tang C., Bujny M. V., Korse H. J., Kwaks T., Otterstrom J. J. et al. 2013; Mechanisms of hemagglutinin targeted influenza virus neutralization. PLoS One8:e80034 [CrossRef][PubMed]
    [Google Scholar]
  5. Cantarella G., Liniger M., Zuniga A., Schiller J. T., Billeter M., Naim H. Y., Glueck R.. 2009; Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma. Vaccine27:3385–3390 [CrossRef][PubMed]
    [Google Scholar]
  6. Guerbois M., Moris A., Combredet C., Najburg V., Ruffié C., Février M., Cayet N., Brandler S., Schwartz O. et al. 2009; Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic. Virology388:191–203 [CrossRef][PubMed]
    [Google Scholar]
  7. Kim E., Okada K., Beeler J. A., Crim R. L., Piedra P. A., Gilbert B. E., Gambotto A.. 2014; Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model. J Virol88:5100–5108 [CrossRef][PubMed]
    [Google Scholar]
  8. Li M., Schmitt P. T., Li Z., McCrory T. S., He B., Schmitt A. P.. 2009; Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol83:7261–7272 [CrossRef][PubMed]
    [Google Scholar]
  9. Liniger M., Zuniga A., Morin T. N., Combardiere B., Marty R., Wiegand M., Ilter O., Knuchel M., Naim H. Y.. 2009; Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. Vaccine27:3299–3305 [CrossRef][PubMed]
    [Google Scholar]
  10. McLean H. Q., Fiebelkorn A. P., Temte J. L., Wallace G. S.. Centers for Disease Control and Prevention 2013; Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep62:1–34[PubMed]
    [Google Scholar]
  11. Mok H., Cheng X., Xu Q., Zengel J. R., Parhy B., Zhao J., Wang C. K., Jin H.. 2012; Evaluation of measles vaccine virus as a vector to deliver respiratory syncytial virus fusion protein or Epstein-Barr virus glycoprotein gp350. Open Virol J6:12–22 [CrossRef][PubMed]
    [Google Scholar]
  12. Mourez T., Mesel-Lemoine M., Combredet C., Najburg V., Cayet N., Tangy F.. 2011; A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells. Virology419:117–125 [CrossRef][PubMed]
    [Google Scholar]
  13. Parks C. L., Lerch R. A., Walpita P., Sidhu M. S., Udem S. A.. 1999; Enhanced measles virus cDNA rescue and gene expression after heat shock. J Virol73:3560–3566[PubMed]
    [Google Scholar]
  14. Prince G. A., Jenson A. B., Horswood R. L., Camargo E., Chanock R. M.. 1978; The pathogenesis of respiratory syncytial virus infection in cotton rats. Am J Pathol93:771–791[PubMed]
    [Google Scholar]
  15. Prince G. A., Potash L., Horswood R. L., Camargo E., Suffin S. C., Johnson R. A., Chanock R. M.. 1979; Intramuscular inoculation of live respiratory syncytial virus induces immunity in cotton rats. Infect Immun23:723–728[PubMed]
    [Google Scholar]
  16. Prince G. A., Horswood R. L., Chanock R. M.. 1985; Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol55:517–520[PubMed]
    [Google Scholar]
  17. Radecke F., Spielhofer P., Schneider H., Kaelin K., Huber M., Dötsch C., Christiansen G., Billeter M. A.. 1995; Rescue of measles viruses from cloned DNA. EMBO J14:5773–5784[PubMed]
    [Google Scholar]
  18. Ramsauer K., Schwameis M., Firbas C., Müllner M., Putnak R. J., Thomas S. J., Desprès P., Tauber E., Jilma B. et al. 2015; Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet Infect Dis15:519–527 [CrossRef][PubMed]
    [Google Scholar]
  19. Rennick L. J., de Vries R. D., Carsillo T. J., Lemon K., van Amerongen G., Ludlow M., Nguyen D. T., Yüksel S., Verburgh R. J. et al. 2015; Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates. J Virol89:2192–2200 [CrossRef][PubMed]
    [Google Scholar]
  20. Sawada A., Komase K., Nakayama T.. 2011; AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats. Vaccine29:1481–1490 [CrossRef][PubMed]
    [Google Scholar]
  21. Schwarzer S., Reibel S., Lang A. B., Struck M. M., Finkel B., Gerike E., Tischer A., Gassner M., Glück R. et al. 1998; Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines. Vaccine16:298–304 [CrossRef][PubMed]
    [Google Scholar]
  22. Singh M., Cattaneo R., Billeter M. A.. 1999; A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice. J Virol73:4823–4828[PubMed]
    [Google Scholar]
  23. Spielhofer P., Bächi T., Fehr T., Christiansen G., Cattaneo R., Kaelin K., Billeter M. A., Naim H. Y.. 1998; Chimeric measles viruses with a foreign envelope. J Virol72:2150–2159[PubMed]
    [Google Scholar]
  24. Storch G. A.. 1998; Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. Pediatrics102:648–651 [CrossRef][PubMed]
    [Google Scholar]
  25. Tangy F., Naim H. Y.. 2005; Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector. Viral Immunol18:317–326 [CrossRef][PubMed]
    [Google Scholar]
  26. Throsby M., van den Brink E., Jongeneelen M., Poon L. L., Alard P., Cornelissen L., Bakker A., Cox F., van Deventer E. et al. 2008; Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One3:e3942 [CrossRef][PubMed]
    [Google Scholar]
  27. Wang Z., Hangartner L., Cornu T. I., Martin L. R., Zuniga A., Billeter M. A., Naim H. Y.. 2001; Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses. Vaccine19:2329–2336 [CrossRef][PubMed]
    [Google Scholar]
  28. Welliver T. P., Garofalo R. P., Hosakote Y., Hintz K. H., Avendano L., Sanchez K., Velozo L., Jafri H., Chavez-Bueno S. et al. 2007; Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis195:1126–1136 [CrossRef][PubMed]
    [Google Scholar]
  29. Widjojoatmodjo M. N., Bogaert L., Meek B., Zahn R., Vellinga J., Custers J., Serroyen J., Radošević K., Schuitemaker H.. 2015; Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats. Vaccine33:5406–5414 [CrossRef][PubMed]
    [Google Scholar]
  30. Wu H., Pfarr D. S., Johnson S., Brewah Y. A., Woods R. M., Patel N. K., White W. I., Young J. F., Kiener P. A.. 2007; Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Mol Biol368:652–665 [CrossRef][PubMed]
    [Google Scholar]
  31. Yamaji Y., Nakayama T.. 2014; Recombinant measles viruses expressing respiratory syncytial virus proteins induced virus-specific CTL responses in cotton rats. Vaccine32:4529–4536 [CrossRef][PubMed]
    [Google Scholar]
  32. Zuniga A., Liniger M., Morin T. N., Marty R. R., Wiegand M., Ilter O., Weibel S., Billeter M. A., Knuchel M. C. et al. 2013; Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector. Hum Vaccin Immunother9:607–613 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000523
Loading
/content/journal/jgv/10.1099/jgv.0.000523
Loading

Data & Media loading...

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error